|
Resolution: standard / high Figure 3.
Upper panel : (3A) MPO-ANCA inhibition assay. Incubation with increasing concentrations
of myeloperoxidase (MPO) (1 – 20 μg/mL) leads to a reduction in MPO-ANCA reactivity
(■). In contrast, incubation with human Heat Shock Protein 60 (hHSP60) (1 – 20 μg/mL)
does not decrease MPO-ANCA reactivity (●). Lower panel: (3B) Anti-human Heat Shock
Protein 60 (hHSP60) inhibition assay. Incubation with increasing concentrations of
myeloperoxidase (MPO) (1 – 20 μg/mL) does not lead to a reduction in anti-hHSP60 reactivity
(■). However, incubation with hHSP60 (1 – 20 μg/mL) only slightly decreases anti-hHSP60
reactivity (●)
Slot et al. Journal of Autoimmune Diseases 2006 3:4 doi:10.1186/1740-2557-3-4 |